hypericin

hypericin is a lipid of Polyketides (PK) class. Hypericin is associated with abnormalities such as Dermatitis, Phototoxic, Dehydration, Photosensitization, Morphologically altered structure and Myocardial Infarction. The involved functions are known as Cell Cycle Checkpoints, Apoptosis, Acetylation, Cell Survival and Caspase Activation. Hypericin often locates in insoluble fraction, Cytoplasmic matrix, Protoplasm, Tissue membrane and Cytoplasm. The associated genes with hypericin are CDC37 gene, HSPA8 gene, RAF1 gene, cyclin H and FK228. The related lipids are Phosphatidylserines.

Cross Reference

Introduction

To understand associated biological information of hypericin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with hypericin?

hypericin is suspected in Dermatitis, Phototoxic, Photosensitization, Pneumonia, Psoriasis, Phototoxicity, Chronic infectious disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with hypericin

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uterine Cervical Neoplasms D002583 10 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Neoplasms, Radiation-Induced D009381 3 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Skin Neoplasms D012878 12 associated lipids
Burns D002056 34 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Cataract D002386 34 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Neoplasm Recurrence, Local D009364 5 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteolysis D010014 8 associated lipids
Brain Neoplasms D001932 15 associated lipids
Per page 10 20 50 | Total 38

PubChem Associated disorders and diseases

What pathways are associated with hypericin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with hypericin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with hypericin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with hypericin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with hypericin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with hypericin?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with hypericin

Download all related citations
Per page 10 20 50 100 | Total 1000
Authors Title Published Journal PubMed Link
Zubek S et al. Hypericin and pseudohypericin concentrations of a valuable medicinal plant Hypericum perforatum L. are enhanced by arbuscular mycorrhizal fungi. 2012 Mycorrhiza pmid:21626142
Olivo M et al. Altered expression of cell adhesion molecules leads to differential uptake of hypericin in urothelial cancer. 2012 Urol. Oncol. pmid:20933443
López-Chicón P et al. On the mechanism of Candida spp. photoinactivation by hypericin. 2012 Photochem. Photobiol. Sci. pmid:22566080
Sharma KV and Davids LM Depigmentation in melanomas increases the efficacy of hypericin-mediated photodynamic-induced cell death. 2012 Photodiagnosis Photodyn Ther pmid:22594986
Kairyte K et al. Effective inactivation of food pathogens Listeria monocytogenes and Salmonella enterica by combined treatment of hypericin-based photosensitization and high power pulsed light. 2012 J. Appl. Microbiol. pmid:22469030
Camas N et al. Secondary metabolites of Hypericum leptophyllum Hochst., an endemic Turkish species. 2012 ScientificWorldJournal pmid:22649295
Mañero FJ et al. Elicitation of secondary metabolism in Hypericum perforatum by rhizosphere bacteria and derived elicitors in seedlings and shoot cultures. 2012 Pharm Biol pmid:22900596
Rubio N et al. Spatiotemporal autophagic degradation of oxidatively damaged organelles after photodynamic stress is amplified by mitochondrial reactive oxygen species. 2012 Autophagy pmid:22889744
Eriksson ES and Eriksson LA Identifying the sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA) as a potential target for hypericin--a theoretical study. 2012 Phys Chem Chem Phys pmid:22892582
Li JJ et al. A single-dose toxicity study on non-radioactive iodinated hypericin for a targeted anticancer therapy in mice. 2012 Acta Pharmacol. Sin. pmid:23103619
Weberschock T et al. Interventions for mycosis fungoides. 2012 Cochrane Database Syst Rev pmid:22972128
Ritz R et al. Hypericin for visualization of high grade gliomas: first clinical experience. 2012 Eur J Surg Oncol pmid:22284346
van den Berg NS et al. Fluorescence guidance in urologic surgery. 2012 Curr Opin Urol pmid:22262249
Richard AJ et al. St. John's Wort inhibits insulin signaling in murine and human adipocytes. 2012 Biochim. Biophys. Acta pmid:22198320
Vanlangenakker N et al. Many stimuli pull the necrotic trigger, an overview. 2012 Cell Death Differ. pmid:22075985
Brechner ML et al. Effects of UV-B on secondary metabolites of St. John's Wort (Hypericum perforatum L.) grown in controlled environments. 2011 May-Jun Photochem. Photobiol. pmid:21275996
Mondon K et al. MPEG-hexPLA micelles as novel carriers for hypericin, a fluorescent marker for use in cancer diagnostics. 2011 Mar-Apr Photochem. Photobiol. pmid:21166812
Buriankova L et al. Kinetics of hypericin association with low-density lipoproteins. 2011 Jan-Feb Photochem. Photobiol. pmid:21114669
Vandepitte J et al. Biodistribution and photodynamic effects of polyvinylpyrrolidone-hypericin using multicellular spheroids composed of normal human urothelial and T24 transitional cell carcinoma cells. 2011 Jan-Feb J Biomed Opt pmid:21280926
Schug TT Targeting transcription through inhibition of TBP. 2011 Jan-Feb Oncotarget pmid:21378415
Morachis JM et al. Identification of kinase inhibitors that target transcription initiation by RNA polymerase II. 2011 Jan-Feb Oncotarget pmid:21378408
Zhao J et al. Plant-derived bioactive compounds produced by endophytic fungi. 2011 Mini Rev Med Chem pmid:21222580
Boiy A et al. Photodynamic therapy using topically applied hypericin: comparative effect with methyl-aminolevulinic acid on UV induced skin tumours. 2011 J. Photochem. Photobiol. B, Biol. pmid:21035351
Roelants M et al. Human serum albumin as key mediator of the differential accumulation of hypericin in normal urothelial cell spheroids versus urothelial cell carcinoma spheroids. 2011 Photochem. Photobiol. Sci. pmid:21103512
Sorrentino F et al. Hypericins and thioredoxin reductase: Biochemical and docking studies disclose the molecular basis for effective inhibition by naphthodianthrones. 2011 Bioorg. Med. Chem. pmid:21106380
Li J et al. A dual-targeting anticancer approach: soil and seed principle. 2011 Radiology pmid:21712473
Noell S et al. Selective enrichment of hypericin in malignant glioma: pioneering in vivo results. 2011 Int. J. Oncol. pmid:21399870
Ghazanfarpour M et al. Hypericum perforatum for the treatment of premenstrual syndrome. 2011 Int J Gynaecol Obstet pmid:21315349
Couldwell WT et al. A phase 1/2 study of orally administered synthetic hypericin for treatment of recurrent malignant gliomas. 2011 Cancer pmid:21456013
Patel P et al. Emerging endoscopic and photodynamic techniques for bladder cancer detection and surveillance. 2011 ScientificWorldJournal pmid:22235185
Song S et al. Small-animal PET of tumor damage induced by photothermal ablation with 64Cu-bis-DOTA-hypericin. 2011 J. Nucl. Med. pmid:21498539
Ni G et al. The possible use of hypericin to overcome drug resistance in cancer treatment. 2011 Chem. Biol. Interact. pmid:21168397
Sačková V et al. Enhanced antiproliferative and apoptotic response of HT-29 adenocarcinoma cells to combination of photoactivated hypericin and farnesyltransferase inhibitor manumycin A. 2011 Int J Mol Sci pmid:22272079
Cao X et al. Isolation and purification of series bioactive components from Hypericum perforatum L. by counter-current chromatography. 2011 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:21306961
Bánó G et al. On the diffusion of hypericin in dimethylsulfoxide/water mixtures-the effect of aggregation. 2011 J Phys Chem B pmid:21332112
Bhuvaneswari R et al. Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model. 2011 Lasers Surg Med pmid:22057493
Sanovic R et al. Low dose hypericin-PDT induces complete tumor regression in BALB/c mice bearing CT26 colon carcinoma. 2011 Photodiagnosis Photodyn Ther pmid:22122915
Hao PF et al. [Study on the enzyme extraction process of hypericin by pectinase]. 2011 Zhong Yao Cai pmid:22066412
Marysael T et al. Influence of the vascular damaging agents DMXAA and ZD6126 on hypericin distribution and accumulation in RIF-1 tumors. 2011 J. Cancer Res. Clin. Oncol. pmid:21858709
Onoue S et al. In vitro photochemical and phototoxicological characterization of major constituents in St. John's Wort (Hypericum perforatum) extracts. 2011 Phytochemistry pmid:21782201
Crockett SL and Boevé JL Flavonoid glycosides and naphthodianthrones in the sawfly Tenthredo zonula and its host-plants, Hypericum perforatum and H. hirsutum. 2011 J. Chem. Ecol. pmid:21814831
Helmja K et al. Variation in the composition of the essential oils, phenolic compounds and mineral elements of Hypericum perforatum L. growing in Estonia. 2011 Nat. Prod. Res. pmid:21391113
Rainha N et al. Comparison of the endemic Azorean Hypericum foliosum with other Hypericum species: antioxidant activity and phenolic profile. 2011 Nat. Prod. Res. pmid:21246439
Park S et al. Immunomodulatory Effects of Hypocrellin A on MHC-restricted Antigen Processing. 2011 Immune Netw pmid:22346783
Shrestha R et al. A high-precision micropipette sensor for cellular-level real-time thermal characterization. 2011 Sensors (Basel) pmid:22164108
Zdunić G et al. Isolation and identification of phenolic compounds from Hypericum richeri Vill. and their antioxidant capacity. 2011 Nat. Prod. Res. pmid:19764002
Pimentel MR et al. The use of endophytes to obtain bioactive compounds and their application in biotransformation process. 2011 Biotechnol Res Int pmid:21350663
Crupi R et al. Hypericum perforatum treatment: effect on behaviour and neurogenesis in a chronic stress model in mice. 2011 BMC Complement Altern Med pmid:21272291
Kumagai A et al. A potent inhibitor of SIK2, 3, 3', 7-trihydroxy-4'-methoxyflavon (4'-O-methylfisetin), promotes melanogenesis in B16F10 melanoma cells. 2011 PLoS ONE pmid:22022544
Martirosyan AS et al. Biphasic dose-response of antioxidants in hypericin-induced photohemolysis. 2011 Photodiagnosis Photodyn Ther pmid:21864803